User profiles for "author:Filippo Fagni"

Filippo Fagni

Department of Internal Medicine 3, Friedrich-Alexander University Erlangen-Nuermberg …
Verified email at uk-erlangen.de
Cited by 797

[HTML][HTML] COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses

F Fagni, D Simon, K Tascilar, V Schoenau… - The Lancet …, 2021 - thelancet.com
At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …

[HTML][HTML] Eosinophilic granulomatosis with polyangiitis: dissecting the pathophysiology

F Fagni, F Bello, G Emmi - Frontiers in Medicine, 2021 - frontiersin.org
Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare multisystemic disease
classified both amongst hypereosinophilic disorders and ANCA-associated vasculitis …

SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases

D Simon, K Tascilar, F Fagni, G Krönke… - Annals of the …, 2021 - ard.bmj.com
Objectives To better understand the factors that influence the humoral immune response to
vaccination against SARS-CoV-2 in patients with immune-mediated inflammatory diseases …

Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study

A Bettiol, ML Urban, L Dagna, V Cottin… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic
granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the …

Imaging in inflammatory arthritis: progress towards precision medicine

I Minopoulou, A Kleyer, M Yalcin-Mutlu… - Nature Reviews …, 2023 - nature.com
Imaging techniques such as ultrasonography and MRI have gained ground in the diagnosis
and management of inflammatory arthritis, as these imaging modalities allow a sensitive …

Humoral and cellular immune responses to SARS–CoV‐2 infection and vaccination in autoimmune disease patients with B cell depletion

D Simon, K Tascilar, K Schmidt, B Manger… - Arthritis & …, 2022 - Wiley Online Library
Objective B cell depletion is an established therapeutic principle in a wide range of
autoimmune diseases. However, B cells are also critical for inducing protective immunity …

Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: a multicentre study

F Fagni, A Bettiol, R Talarico, G Lopalco… - Annals of the …, 2020 - ard.bmj.com
Objective To evaluate the effectiveness and safety of secukinumab in patients with a
mucosal and articular Behçet's phenotype resistant to conventional and biologic treatment …

Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease

D Simon, K Tascilar, F Fagni, K Schmidt… - Annals of the …, 2022 - ard.bmj.com
Objectives To test whether patients with immune-mediated inflammatory disease (IMIDs),
who did not respond to two doses of the SARS-CoV-2 vaccine, develop protective immunity …

[HTML][HTML] Patient's perception of digital symptom assessment technologies in rheumatology: results from a multicentre study

J Knitza, F Muehlensiepen, Y Ignatyev… - Frontiers in Public …, 2022 - frontiersin.org
Introduction An increasing number of digital tools, including dedicated diagnostic decision
support systems (DDSS) exist to better assess new symptoms and understand when and …

[HTML][HTML] DeepNAPSI multi-reader nail psoriasis prediction using deep learning

L Folle, P Fenzl, F Fagni, M Thies, V Christlein… - Scientific Reports, 2023 - nature.com
Nail psoriasis occurs in about every second psoriasis patient. Both, finger and toe nails can
be affected and also severely destroyed. Furthermore, nail psoriasis is associated with a …